Trial Profile
Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Dalteparin sodium (Primary) ; Heparin
- Indications Embolism and thrombosis
- Focus Pharmacodynamics
- Acronyms HALO
- 25 Jul 2013 Planned end date changed from 1 Sep 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.
- 31 Jul 2012 New trial record